Compare CORAL LAB. with Zandu Realty - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs ZANDU REALTY - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CORAL LAB. ZANDU REALTY CORAL LAB./
ZANDU REALTY
 
P/E (TTM) x 9.5 24.2 39.2% View Chart
P/BV x 0.9 0.8 113.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 CORAL LAB.   ZANDU REALTY
EQUITY SHARE DATA
    CORAL LAB.
Mar-21
ZANDU REALTY
Mar-17
CORAL LAB./
ZANDU REALTY
5-Yr Chart
Click to enlarge
High Rs4431,670 26.5%   
Low Rs951,030 9.2%   
Sales per share (Unadj.) Rs270.563.3 427.3%  
Earnings per share (Unadj.) Rs38.063.9 59.4%  
Cash flow per share (Unadj.) Rs43.563.9 68.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs382.82,438.1 15.7%  
Shares outstanding (eoy) m3.570.81 440.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.021.2 4.7%   
Avg P/E ratio x7.121.0 33.7%  
P/CF ratio (eoy) x6.221.0 29.4%  
Price / Book Value ratio x0.70.6 127.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m9621,089 88.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1023 3,327.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m96651 1,883.5%  
Other income Rs m38117 32.3%   
Total revenues Rs m1,003168 596.9%   
Gross profit Rs m161-37 -432.7%  
Depreciation Rs m200-   
Interest Rs m314 19.9%   
Profit before tax Rs m17665 269.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4114 298.8%   
Profit after tax Rs m13652 261.8%  
Gross profit margin %16.7-72.6 -23.0%  
Effective tax rate %23.020.8 110.9%   
Net profit margin %14.0101.0 13.9%  
BALANCE SHEET DATA
Current assets Rs m1,108270 411.2%   
Current liabilities Rs m278118 235.7%   
Net working cap to sales %86.0295.9 29.1%  
Current ratio x4.02.3 174.4%  
Inventory Days Days13512,983 1.0%  
Debtors Days Days1,4800-  
Net fixed assets Rs m5671,824 31.1%   
Share capital Rs m3681 44.3%   
"Free" reserves Rs m1,3311,894 70.3%   
Net worth Rs m1,3661,975 69.2%   
Long term debt Rs m00-   
Total assets Rs m1,6752,093 80.0%  
Interest coverage x63.25.6 1,131.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60 2,353.3%   
Return on assets %8.33.2 261.9%  
Return on equity %9.92.6 378.4%  
Return on capital %13.14.0 325.0%  
Exports to sales %72.30-   
Imports to sales %2.00-   
Exports (fob) Rs m698NA-   
Imports (cif) Rs m19NA-   
Fx inflow Rs m6980-   
Fx outflow Rs m310-   
Net fx Rs m6680-   
CASH FLOW
From Operations Rs m1159 18.8%  
From Investments Rs m-2-160 1.3%  
From Financial Activity Rs m3101 3.0%  
Net Cashflow Rs m120 4,332.1%  

Share Holding

Indian Promoters % 32.3 35.5 91.0%  
Foreign collaborators % 39.2 0.0 -  
Indian inst/Mut Fund % 0.4 0.1 323.1%  
FIIs % 0.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 28.5 64.5 44.2%  
Shareholders   4,237 22,589 18.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CORAL LAB. With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Indian Indices End Flat Amid Volatility; Asian Paints, Axis Bank & HUL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You(Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

My Best Sectors for 2022(Fast Profits Daily)

Jan 4, 2022

My top 2 sectors for 2022 might surprise you.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CORAL LAB. SHARE PRICE


Jan 14, 2022 (Close)

TRACK CORAL LAB.

  • Track your investment in CORAL LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

CORAL LAB. 8-QTR ANALYSIS

COMPARE CORAL LAB. WITH

MARKET STATS